{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:53:37Z","timestamp":1793087617248,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.trim.2025.102181","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:48:30Z","timestamp":1738273710000},"page":"102181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of tacrolimus time in therapeutic range (TTR) on early post transplantation outcomes"],"prefix":"10.1016","volume":"89","author":[{"given":"Mariano","family":"Berro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Odstrcil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Frassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I","family":"Trucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Paganini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo D.","family":"Kusminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Couriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2025.102181_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.2014.852537","article-title":"Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Locatelli","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.trim.2025.102181_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613644","article-title":"Identification of new soluble factors correlated with the development of graft failure after haploidentical hematopoietic stem cell transplantation","volume":"11","author":"Weber","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102181_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/16078454.2022.2042064","article-title":"Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes","volume":"27","author":"Chen","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.trim.2025.102181_bb0020","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute grafts-versus-host disease \u2013 biological process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2025.102181_bb0025","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3324\/haematol.2019.240309","article-title":"Traslational and clinical advances in graft-versus-host disease","volume":"105","author":"Gooptu","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.trim.2025.102181_bb0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41409-020-01146-0","article-title":"Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease\/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center experience","volume":"56","author":"Berro","year":"2021","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102181_bb0035","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2025.102181_bb0040","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Hematology."},{"issue":"3","key":"10.1016\/j.trim.2025.102181_bb0045","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2352-3026(18)30221-7","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.trim.2025.102181_bb0050","first-page":"37","article-title":"Efficacy, safety, and practicality of tacrolimus monitoring after bone marrow transplant: assessment of a change in practice","volume":"73","author":"Cheung","year":"2020","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.trim.2025.102181_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1078155215577809","article-title":"Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation","volume":"22","author":"Butts","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.trim.2025.102181_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbmt.2015.08.027","article-title":"Influce of absortion, distribution, metabolism, and excretion genomic variants on tacrolimus\/sirolimus blood levels and graft-vesus-host disease after allogeneic hematopoietic cell transplantation","volume":"22","author":"Khaled","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102181_bb0065","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/ijms21030858","article-title":"Influence of germline genetics on tacrolimus pharmacokinetics and pharmacodynamics in allogeneic hematopoietic stem cell transplant patients","volume":"21","author":"Zhu","year":"2020","journal-title":"Int J Molec Sci."},{"key":"10.1016\/j.trim.2025.102181_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40262-015-0339-2","article-title":"Phamacokinetics, pharmacodynamics, and pharmacogenomics of immunosuppressants in allogeneic hematopoietic cell transplantation: par I","volume":"55","author":"McCune","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.trim.2025.102181_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2004.10.008","article-title":"Prognostic factors for outcomes of patients with refractory or relapse acute myelogenous leukemia or myelodisplastic syndrome undergoing allogeneic progenitor cell transplantation","volume":"11","author":"Wong","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102181_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/bmt.2015.323","article-title":"Higher tacrolimus concentrations early after transplant reduce the risk of acute graft-versus-host disease in reduced-intensity allogeneic stem cell transplantation","volume":"51","author":"Ganetsky","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102181_bb0085","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/bmt.2009.327","article-title":"Relationship between tacrolimus blood concentrations and clinical outcome during the first 4 weeks after SCT in children","volume":"45","author":"Watanabe","year":"2010","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.trim.2025.102181_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41409-018-0267-5","article-title":"Low mean post-transplantation tacrolimus levels in weeks 2-3 correlates with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and related donor","volume":"54","author":"Hagen","year":"2019","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.trim.2025.102181_bb0095","doi-asserted-by":"crossref","unstructured":"Olsson R, Logan B, Chaudhury S, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 215;29:1754\u20131762.","DOI":"10.1038\/leu.2015.75"},{"key":"10.1016\/j.trim.2025.102181_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3390\/cancers13040613","article-title":"Effect of early post-transplantation tacrolimus concentration on the risk of acute graft-versus-host disease in allogeneic stem cell transplantation","volume":"13","author":"Sharma","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.trim.2025.102181_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbmt.2011.06.008","article-title":"Effect of early posttransplantation tacrolimus concentration on developmente of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors","volume":"18","author":"Mori","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2025.102181_bb0110","first-page":"37","article-title":"Efficacy, safety, and practicality of tacrolimus monitoring after bone marrow transplantation: assessment of a change in practice","volume":"73","author":"Cheung","year":"2020","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.trim.2025.102181_bb0115","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1517\/17425250903044959","article-title":"Tacrolimus in hematopoietic stem cell transplantation","volume":"5","author":"Fortune","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.trim.2025.102181_bb0120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.05.040","article-title":"Evaluation of tacrolimus sorption to PVC- and non PVC-based tubes in administration sets: pump mthod vs. drip method","volume":"528","author":"Jin","year":"2017","journal-title":"Int J Pham."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T18:23:34Z","timestamp":1740594214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"alternative-id":["S0966327425000097"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102181","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of tacrolimus time in therapeutic range (TTR) on early post transplantation outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102181"}}